UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 17, 2021 5:30 P.M.
Form:
F-1
CIK:
0001836056
Company Name:
Ambrx Biopharma Inc.
File Number:
333-256639